Related Experiment Video
Updated: May 19, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Immunotherapy in allergies: an update
Zamir Calamita1, Simone Bernardino Potthast
1School of Marília, Division of Internal Medicine and Clinical Immunology, Marília, São Paulo, Brazil. calamita@unimedmarila.com.br
Abstract:
The allergen specific immunotherapy is the administration, in IgE-mediated allergic patients, of a specific allergen in a gradually increased number to provide protection against allergic symptoms and inflammatory reaction. The current immunotherapeutic approaches occur by modulating the release of inflammatory mediators involved in allergic reaction and consequently the inhibition of allergic inflammatory process. Since 1997 several World Associations of Allergy, Asthma and Immunology, have reviewed this issue, seeking to establish standards for its use. Also many publications about the immunotherapy's efficacy, as well as, several guidelines on the use of immunotherapy in the treatment of allergic are available. This article will focus on the most current evidence about the immunotherapy in allergies regarding its mechanism of action, effectiveness and practical considerations.
Related Concept Videos
Tumor Immunotherapy
Allergic Reactions
Allergic Reactions: Anaphylaxis
Drug Toxicity: Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions

